Michael Annino/Shutterstock AI

Mining pharma's reshoring rush

It’s time for the U.S. to sift through domestic drug manufacturing efforts

Charting a sustainable path for generics

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

INCOG Biopharma: Pedaling towards excellence

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

Cellares: A disruptive impact on cell therapy

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

ten23 health: Sustainable success

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Raising a modern pharma CDMO

Four young companies built with intention tackle the future of medicine

Excipient-based strategies to harness complex therapeutics

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.
Shutterstock 239423872

Shedding stigmas

Modern-day medications might finally mean obesity can be viewed as treatable
Screen Shot 2023 09 06 At 11 17 20 Am

Bridging the gap between R&D and GMP

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
Shutterstock 1907619631

Optimizing mRNA therapeutics

Novel techniques for mRNA delivery, capping and more will be key to producing more effective vaccines
Shutterstock 1664112631

Meeting biopharma’s infrastructure demands

Biopharma facilities must address the specific needs and concerns of this dynamic sector
Shutterstock 2224667693

OSD spreads its wings

Bright ideas are helping drugs and butterflies take flight
Microsoft Teams Image (1)

OSD soars: Evolution of oral solid dose technology

In phase 2 of our OSD series, we cover the resurgence of fixed-dose combinations and the pursuit of effective oral delivery for biologics
Microsoft Teams Image (2)

OSD soars: The digital metamorphosis

In phase III of our OSD series, we cover what's on the horizon for the digital metamorphosis of drug delivery, including 3D printing and robot pills.

Surrendering to the pharma magic

The science of ADCs makes for an incredible show